<?xml version='1.0' encoding='utf-8'?>
<document id="21708882"><sentence text="Efflux transport is an important determinant of ethinylestradiol glucuronide and ethinylestradiol sulfate pharmacokinetics."><entity charOffset="48-76" id="DDI-PubMed.21708882.s1.e0" text="ethinylestradiol glucuronide" /><entity charOffset="81-105" id="DDI-PubMed.21708882.s1.e1" text="ethinylestradiol sulfate" /><pair ddi="false" e1="DDI-PubMed.21708882.s1.e0" e2="DDI-PubMed.21708882.s1.e0" /><pair ddi="false" e1="DDI-PubMed.21708882.s1.e0" e2="DDI-PubMed.21708882.s1.e1" /></sentence><sentence text="17α-ethinylestradiol (EE) undergoes extensive conjugation to 17α-ethinylestradiol-3-O-glucuronide (EEG) and 17α-ethinylestradiol-3-O-sulfate (EES)"><entity charOffset="0-20" id="DDI-PubMed.21708882.s2.e0" text="17α-ethinylestradiol" /><entity charOffset="22-24" id="DDI-PubMed.21708882.s2.e1" text="EE" /><entity charOffset="61-97" id="DDI-PubMed.21708882.s2.e2" text="17α-ethinylestradiol-3-O-glucuronide" /><entity charOffset="99-102" id="DDI-PubMed.21708882.s2.e3" text="EEG" /><entity charOffset="108-140" id="DDI-PubMed.21708882.s2.e4" text="17α-ethinylestradiol-3-O-sulfate" /><entity charOffset="142-145" id="DDI-PubMed.21708882.s2.e5" text="EES" /><pair ddi="false" e1="DDI-PubMed.21708882.s2.e0" e2="DDI-PubMed.21708882.s2.e0" /><pair ddi="false" e1="DDI-PubMed.21708882.s2.e0" e2="DDI-PubMed.21708882.s2.e1" /><pair ddi="false" e1="DDI-PubMed.21708882.s2.e0" e2="DDI-PubMed.21708882.s2.e2" /><pair ddi="false" e1="DDI-PubMed.21708882.s2.e0" e2="DDI-PubMed.21708882.s2.e3" /><pair ddi="false" e1="DDI-PubMed.21708882.s2.e0" e2="DDI-PubMed.21708882.s2.e4" /><pair ddi="false" e1="DDI-PubMed.21708882.s2.e0" e2="DDI-PubMed.21708882.s2.e5" /><pair ddi="false" e1="DDI-PubMed.21708882.s2.e1" e2="DDI-PubMed.21708882.s2.e1" /><pair ddi="false" e1="DDI-PubMed.21708882.s2.e1" e2="DDI-PubMed.21708882.s2.e2" /><pair ddi="false" e1="DDI-PubMed.21708882.s2.e1" e2="DDI-PubMed.21708882.s2.e3" /><pair ddi="false" e1="DDI-PubMed.21708882.s2.e1" e2="DDI-PubMed.21708882.s2.e4" /><pair ddi="false" e1="DDI-PubMed.21708882.s2.e1" e2="DDI-PubMed.21708882.s2.e5" /><pair ddi="false" e1="DDI-PubMed.21708882.s2.e2" e2="DDI-PubMed.21708882.s2.e2" /><pair ddi="false" e1="DDI-PubMed.21708882.s2.e2" e2="DDI-PubMed.21708882.s2.e3" /><pair ddi="false" e1="DDI-PubMed.21708882.s2.e2" e2="DDI-PubMed.21708882.s2.e4" /><pair ddi="false" e1="DDI-PubMed.21708882.s2.e2" e2="DDI-PubMed.21708882.s2.e5" /><pair ddi="false" e1="DDI-PubMed.21708882.s2.e3" e2="DDI-PubMed.21708882.s2.e3" /><pair ddi="false" e1="DDI-PubMed.21708882.s2.e3" e2="DDI-PubMed.21708882.s2.e4" /><pair ddi="false" e1="DDI-PubMed.21708882.s2.e3" e2="DDI-PubMed.21708882.s2.e5" /><pair ddi="false" e1="DDI-PubMed.21708882.s2.e4" e2="DDI-PubMed.21708882.s2.e4" /><pair ddi="false" e1="DDI-PubMed.21708882.s2.e4" e2="DDI-PubMed.21708882.s2.e5" /></sentence><sentence text=" Thus, oral contraceptive drug-drug interaction (DDI) studies usually characterize metabolite pharmacokinetics, with changes typically attributed to modulation of metabolism" /><sentence text=" EE passively diffuses through plasma membranes, but its conjugates are hydrophilic and require active transport"><entity charOffset="1-3" id="DDI-PubMed.21708882.s4.e0" text="EE" /></sentence><sentence text=" Unlike EE metabolism, EEG and EES transport has not been explored in vivo as a potential mechanism of DDIs"><entity charOffset="8-9" id="DDI-PubMed.21708882.s5.e0" text="EE" /><entity charOffset="23-24" id="DDI-PubMed.21708882.s5.e1" text="EE" /><entity charOffset="31-32" id="DDI-PubMed.21708882.s5.e2" text="EE" /><pair ddi="false" e1="DDI-PubMed.21708882.s5.e0" e2="DDI-PubMed.21708882.s5.e0" /><pair ddi="false" e1="DDI-PubMed.21708882.s5.e0" e2="DDI-PubMed.21708882.s5.e1" /><pair ddi="false" e1="DDI-PubMed.21708882.s5.e0" e2="DDI-PubMed.21708882.s5.e2" /><pair ddi="false" e1="DDI-PubMed.21708882.s5.e1" e2="DDI-PubMed.21708882.s5.e1" /><pair ddi="false" e1="DDI-PubMed.21708882.s5.e1" e2="DDI-PubMed.21708882.s5.e2" /></sentence><sentence text=" Recent in vitro studies demonstrated that EEG is transported by multidrug resistance-associated protein (MRP) 2 and MRP3 and EES is a breast cancer resistance protein (BCRP) substrate"><entity charOffset="43-44" id="DDI-PubMed.21708882.s6.e0" text="EE" /><entity charOffset="126-127" id="DDI-PubMed.21708882.s6.e1" text="EE" /><pair ddi="false" e1="DDI-PubMed.21708882.s6.e0" e2="DDI-PubMed.21708882.s6.e0" /><pair ddi="false" e1="DDI-PubMed.21708882.s6.e0" e2="DDI-PubMed.21708882.s6.e1" /></sentence><sentence text=" In the study presented here, pharmacokinetics of EE and conjugates were studied in TR⁻ rats, which lack Mrp2, have marginal hepatic Bcrp expression, and overexpress hepatic Mrp3"><entity charOffset="50-51" id="DDI-PubMed.21708882.s7.e0" text="EE" /></sentence><sentence text=" EE pharmacokinetics in TR⁻ rats were comparable to wild type; however, EEG and EES systemic exposures were altered markedly"><entity charOffset="1-2" id="DDI-PubMed.21708882.s8.e0" text="EE" /><entity charOffset="72-73" id="DDI-PubMed.21708882.s8.e1" text="EE" /><entity charOffset="80-81" id="DDI-PubMed.21708882.s8.e2" text="EE" /><pair ddi="false" e1="DDI-PubMed.21708882.s8.e0" e2="DDI-PubMed.21708882.s8.e0" /><pair ddi="false" e1="DDI-PubMed.21708882.s8.e0" e2="DDI-PubMed.21708882.s8.e1" /><pair ddi="false" e1="DDI-PubMed.21708882.s8.e0" e2="DDI-PubMed.21708882.s8.e2" /><pair ddi="false" e1="DDI-PubMed.21708882.s8.e1" e2="DDI-PubMed.21708882.s8.e1" /><pair ddi="false" e1="DDI-PubMed.21708882.s8.e1" e2="DDI-PubMed.21708882.s8.e2" /></sentence><sentence text=" EEG exposure was greatly increased: 20-fold and &gt;100-fold after intravenous and oral EE administration, respectively"><entity charOffset="1-2" id="DDI-PubMed.21708882.s9.e0" text="EE" /><entity charOffset="86-87" id="DDI-PubMed.21708882.s9.e1" text="EE" /><pair ddi="false" e1="DDI-PubMed.21708882.s9.e0" e2="DDI-PubMed.21708882.s9.e0" /><pair ddi="false" e1="DDI-PubMed.21708882.s9.e0" e2="DDI-PubMed.21708882.s9.e1" /></sentence><sentence text=" In contrast, EES exposure was lower in TR⁻ rats: 65% decreased (intravenously) and 83% decreased (orally)"><entity charOffset="14-15" id="DDI-PubMed.21708882.s10.e0" text="EE" /></sentence><sentence text=" In intestinal and liver perfusions, EE intestinal permeability and metabolism and hepatic clearance were unchanged in TR⁻ rats; however, secretion of EEG into intestinal lumen was halved, EEG was not detected in TR⁻ bile, and EES biliary excretion was 98% decreased"><entity charOffset="37-38" id="DDI-PubMed.21708882.s11.e0" text="EE" /><entity charOffset="151-152" id="DDI-PubMed.21708882.s11.e1" text="EE" /><entity charOffset="189-190" id="DDI-PubMed.21708882.s11.e2" text="EE" /><entity charOffset="227-228" id="DDI-PubMed.21708882.s11.e3" text="EE" /><pair ddi="false" e1="DDI-PubMed.21708882.s11.e0" e2="DDI-PubMed.21708882.s11.e0" /><pair ddi="false" e1="DDI-PubMed.21708882.s11.e0" e2="DDI-PubMed.21708882.s11.e1" /><pair ddi="false" e1="DDI-PubMed.21708882.s11.e0" e2="DDI-PubMed.21708882.s11.e2" /><pair ddi="false" e1="DDI-PubMed.21708882.s11.e0" e2="DDI-PubMed.21708882.s11.e3" /><pair ddi="false" e1="DDI-PubMed.21708882.s11.e1" e2="DDI-PubMed.21708882.s11.e1" /><pair ddi="false" e1="DDI-PubMed.21708882.s11.e1" e2="DDI-PubMed.21708882.s11.e2" /><pair ddi="false" e1="DDI-PubMed.21708882.s11.e1" e2="DDI-PubMed.21708882.s11.e3" /><pair ddi="false" e1="DDI-PubMed.21708882.s11.e2" e2="DDI-PubMed.21708882.s11.e2" /><pair ddi="false" e1="DDI-PubMed.21708882.s11.e2" e2="DDI-PubMed.21708882.s11.e3" /></sentence><sentence text=" After oral EE administration to Mrp2- and Bcrp-knockout mice, EEG exposure increased 46- and 2-fold, respectively, whereas EES concentrations were decreased modestly"><entity charOffset="12-13" id="DDI-PubMed.21708882.s12.e0" text="EE" /><entity charOffset="63-64" id="DDI-PubMed.21708882.s12.e1" text="EE" /><entity charOffset="124-125" id="DDI-PubMed.21708882.s12.e2" text="EE" /><pair ddi="false" e1="DDI-PubMed.21708882.s12.e0" e2="DDI-PubMed.21708882.s12.e0" /><pair ddi="false" e1="DDI-PubMed.21708882.s12.e0" e2="DDI-PubMed.21708882.s12.e1" /><pair ddi="false" e1="DDI-PubMed.21708882.s12.e0" e2="DDI-PubMed.21708882.s12.e2" /><pair ddi="false" e1="DDI-PubMed.21708882.s12.e1" e2="DDI-PubMed.21708882.s12.e1" /><pair ddi="false" e1="DDI-PubMed.21708882.s12.e1" e2="DDI-PubMed.21708882.s12.e2" /></sentence><sentence text=" In conclusion, altered efflux transport resulted in major alterations of EEG and EES pharmacokinetics, highlighting transport as a potential site of DDIs with EE conjugates"><entity charOffset="74-75" id="DDI-PubMed.21708882.s13.e0" text="EE" /><entity charOffset="82-83" id="DDI-PubMed.21708882.s13.e1" text="EE" /><entity charOffset="160-161" id="DDI-PubMed.21708882.s13.e2" text="EE" /><pair ddi="false" e1="DDI-PubMed.21708882.s13.e0" e2="DDI-PubMed.21708882.s13.e0" /><pair ddi="false" e1="DDI-PubMed.21708882.s13.e0" e2="DDI-PubMed.21708882.s13.e1" /><pair ddi="false" e1="DDI-PubMed.21708882.s13.e0" e2="DDI-PubMed.21708882.s13.e2" /><pair ddi="false" e1="DDI-PubMed.21708882.s13.e1" e2="DDI-PubMed.21708882.s13.e1" /><pair ddi="false" e1="DDI-PubMed.21708882.s13.e1" e2="DDI-PubMed.21708882.s13.e2" /></sentence><sentence text="" /></document>